Phibro (PAHC) Director Jonathan Bendheim Receives RSU Award

What Happened
Jonathan Bendheim, a director of Phibro Animal Health Corp (PAHC), was granted 2,716 restricted stock units (RSUs) on August 6, 2026. The grant is reported as an award (code A) with an acquisition price of $0.00 (total reported value $0). Each RSU is a contingent right to one share of Class A common stock and does not represent immediate share ownership until vesting.

Key Details

• Transaction date: 2026-08-06 (Form 4 filed 2026-08-10). Reported as award (A).
• Shares/units granted: 2,716 RSUs; reported acquisition price $0.00 (total $0).
• Vesting: RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2026 (Aug 1, 2027; Aug 1, 2028; Aug 1, 2029), subject to continued service.
• Shares owned after transaction: Not specified in the filing.
• Filing timeliness: Filing date (Aug 10, 2026) corresponds to the required two-business-day window for a change reported Aug 6, 2026 (timely).

Context
RSU grants are a common form of director compensation and are conditional awards that convert to actual shares only as they vest. Because this was an award (not an open-market purchase or sale), it does not indicate immediate buying or selling pressure in the stock.